UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
(Exact name of registrant as specified in its charter)
Commission file number
| |
| |
| (State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification No.) |
| |
| |
| (Address of principal executive offices) |
(Zip Code) |
+
(Registrant’s telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered | ||
| |
|
|
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
| Item 5.02. | Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
| (d) | Election of New Director. |
On June 19, 2020, the Board of Directors of Perrigo Company plc (the “Company” or “Perrigo”) appointed Katherine C. Doyle to serve as a director of the Company and a member of its Audit Committee, to be effective July 29, 2020.
From 2016 to 2019, Ms. Doyle served as the Chief Executive Officer of Swanson Health Products, Inc., an e-commerce health and wellness self-care company. Prior to that, Ms. Doyle was an independent consultant to direct-to-consumer wellness businesses from 2014 to 2016. Ms. Doyle previously worked at Abbott Laboratories in various executive leadership roles from 2011 to 2014, including President of the Abbott Nutrition Product Division and, before that, Vice President and General Manager of Pediatric Nutrition. Prior to 2011, Ms. Doyle gained more than 20 years of experience at McKinsey & Company, Inc., including 10 years as Principal, working in the consumer packaged goods, consumer healthcare and retail sectors across Europe, Asia, Latin America and Africa. She currently serves as a director of AholdDelhaize, a global omnichannel grocery retailer, where she is the Chair of the Sustainability and Innovation Committee and serves on the Audit Committee. Previously, she served on the board of Bemis Company, Inc., a former publicly traded global packaging company, where she served on its Audit and Nomination and Governance Committees.
Murray S. Kessler, President and CEO of Perrigo, said: “We are delighted to welcome Katie to Perrigo’s Board of Directors and Audit Committee. Her impressive executive leadership experience, together with her consumer products background and experience with e-commerce and retail, will add significant value to Perrigo.”
There are no arrangements or understandings between Ms. Doyle and any other person pursuant to which she was selected as a director of the Company. For her service on the Board, Ms. Doyle will be entitled to receive compensation provided to non-employee directors as approved by the Board and described in the Company’s proxy statement filed on March 27, 2020.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| (Registrant) | ||||||
| PERRIGO COMPANY PLC | ||||||
| By: |
/s/ Todd W. Kingma | |||||
| Dated: June 24, 2020 |
Todd W. Kingma | |||||
| Executive Vice President, General Counsel and Secretary | ||||||
Document and Entity Information |
Jun. 19, 2020 |
|---|---|
| Cover [Abstract] | |
| Entity Registrant Name | PERRIGO Co plc |
| Entity Tax Identification Number | 00-0000000 |
| Amendment Flag | false |
| Entity Central Index Key | 0001585364 |
| Document Type | 8-K |
| Document Period End Date | Jun. 19, 2020 |
| Entity File Number | 001-36353 |
| Entity Incorporation State Country Code | L2 |
| Entity Address, Address Line One | The Sharp Building |
| Entity Address, Address Line Two | Hogan Place |
| Entity Address, City or Town | Dublin 2 |
| Entity Address, Country | IE |
| Entity Address, Postal Zip Code | D02 TY74 |
| City Area Code | 353 1 |
| Local Phone Number | 7094000 |
| Security 12b Title | Ordinary shares |
| Trading Symbol | PRGO |
| Security Exchange Name | NYSE |
| Written Communications | false |
| Soliciting Material | false |
| Pre Commencement Tender Offer | false |
| Pre Commencement Issuer Tender Offer | false |
| Entity Emerging Growth Company | false |